Navigation Links
Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease
Date:7/17/2008

- Dimebon Improved the Clinical Course of Alzheimer's Disease; Patients Experienced Statistically Significant Improvements in Memory and Thinking,

Activities of Daily Living, Behavior and Overall Function -

SAN FRANCISCO, July 17 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced publication of the results of its first Alzheimer's disease pivotal clinical trial of the investigational drug Dimebon in the July 19, 2008 issue of The Lancet. In this double-blind, placebo-controlled trial, patients with mild-to-moderate Alzheimer's disease treated with Dimebon experienced statistically significant improvements compared to placebo in all the key aspects of the disease: memory and thinking, activities of daily living, behavior and overall function.

After both six months and a full year of treatment, Dimebon-treated patients were significantly better than placebo-treated patients on all key aspects of the disease. The benefit on the primary endpoint, the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) at six months, was highly significant (p<0.0001). Patients treated with Dimebon were also significantly improved at six months over baseline on all measures (p=0.005 on ADAS-cog). Dimebon's benefit over placebo continued to increase throughout the 12-month treatment period. At the end of 12 months, Dimebon-treated patients preserved their starting level of function on each measure of Alzheimer's disease.

"In this study, Dimebon improved the clinical course of Alzheimer's disease, which is important given that the natural course is progressive deterioration over time," said Rachelle Doody, M.D., Ph.D., lead author and the Effie Marie Cain Chair in Alzheimer's Disease Research at
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
2. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
3. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
4. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
5. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
6. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
7. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
8. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
11. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...v. 9 Access MediQuip, LLC, the nat...lantable medical device management solutions to th...relocating its corporate headquarters to Lake Mary...nued rapid growth, includes a major expansion of t...open in January 2010 and relocation and expansion ...
(Date:11/9/2009)...ov. 9 Thomson Reuters today anno...eFocus, a leading clinical surveillance solution t... in real-time and respond immediately to improve c.... ,, This upgrade is available to current CareF...Focus 2.0 contains several powerful enhancements t...
(Date:11/9/2009)...9 Shire plc (LSE: SH...aceutical company, today announced the availabilit... Tablets in pharmacies across the United States fo... Disorder ( ADHD ) in children and adolescents a... guanfacine, is the first and only nonscheduled al...
Breaking Medicine Technology:Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7School Kids Parents Should Get Flu Vaccines First 54981 1School Kids Parents Should Get Flu Vaccines First 54981 2School Kids Parents Should Get Flu Vaccines First 54981 3School Kids Parents Should Get Flu Vaccines First 54981 4Tevas Patient First Initiative Highlights Struggle Against High Health Care Costs Reminds Lawmakers of Reform Goals 54977 1Tevas Patient First Initiative Highlights Struggle Against High Health Care Costs Reminds Lawmakers of Reform Goals 54977 2Tevas Patient First Initiative Highlights Struggle Against High Health Care Costs Reminds Lawmakers of Reform Goals 54977 349 Companies Submit Products for First Spine Technology Awards 3B Entries Now Closed 54973 149 Companies Submit Products for First Spine Technology Awards 3B Entries Now Closed 54973 2
... Safety and Efficacy of First-in-Class Neurally Ac...ent of Acute Migraine, LONDON, Sept. 6 CoLucid P...company focusing on therapies for central nervous,...s lead compound COL-144,in the treatment of acute ...fe and effective in relieving migraine headaches. ...
...ept. 5 The Florida,Technology, Research and Schol...versity researcher Dr. Herbert Weissbach, distingu...ecular Biology and,Biotechnology in the Charles E.... (CHS), $184,294 as part of the State University R... (SURECAG). SURECAG was,established by the Florida...
Other Medicine Technology:Phase II Results of COL-144 Presented at European Headache and Migraine Trust International Congress 2008 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3
(Date:11/9/2009)...ov. 9 At a time when the 250,000+ ...ngly concerned about finding affordable health ins...n for 2010. ,, The Today,s Options® Prefer... plan provides a cost-effective and comprehensive ...plement plan. People with Medicare can choose to ...
(Date:11/9/2009)...RNewswire/ -- , , WHAT: All PETCO stores na... workshop facilitated by specially trained in-s...November 14 at 2 p.m. During the 30-minute, ... nutritional needs of, their dogs and... good pet nutrition, receive an assessm...
(Date:11/9/2009)...he December issue of European Urology , the offic..., features an article entitled ,Are Infertile Men ...ctive Case-Control Survey, by Dr. Andrea Salonia e...ty is associated with a number of medical comorbid...ed Charlson Comorbidity Index. , Dr. Andrea Salo...
(Date:11/9/2009)...2009 The first human embryonic stem cell treatmen...hown to restore limb function in rats with neck sp...e clinical trial to include people with cervical d...stration gave Geron Corp. of Menlo Park, Calif., p...iduals with thoracic spinal cord injuries, which o...
(Date:11/9/2009)...ould be severe in this group of women, study finds...- Pregnant women who are depressed may suffer seve...y suggests. , Ohio State University researchers...es from 22 pregnant women before they received a s...of depression had a stronger inflammatory response...
Breaking Medicine News(10 mins):Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2Health News:European Urology: Male factor infertility associated with comorbidities 2Health News:UCI embryonic stem cell therapy restores walking ability in rats with neck injuries 2Health News:Depressed and Pregnant? Flu Shot May Be Needed 2
... of global warming keeps coming up from across the...toxic Californian// seawaters are killing marine l...nues to wreak havoc. A couple of days ago it was r... cliffs) is ice-free and snow bunting birds have m...
...tistics, researchers are sounding a new alarm abou... men.// The overall number of syphilis cases...just 7,177 in 2003 perhaps because of a nationwide...as caught unawares," said study lead author James ...
... were in for, as they tucked into appetizing break...hey had to be rushed to the// hospital due to food...ood poisoning in China. Many cooks in china have b...adequately boiled, experts conjecture. Further, it...
...ranted early retirement in the past three years, e... illnesses,// parliament was informed Thursday. ...s of the army, navy and air force and 37,865 were ...reak up, the minister said 1,119 army officers had...
...ne thing and to realize that it could send your ca...ealth and resources may just be the last nail in t...up more than they can afford in Ontario hospitals ...sts. Julia Lelik, a breast cancer patient in...
...e higher the MRSA infection rate, research from// ...aled. The impact of risk management standar...itals study looked at how demanding risk managemen... Institutions with the highest number of 'be...
Other Medicine News:Health News:Norwegian Glacier Shrinks and Marine Life Poisoned as the Globe Warms 2Health News:Norwegian Glacier Shrinks and Marine Life Poisoned as the Globe Warms 3Health News:Syphilis Rate on Rise in US Gay, Bisexual Men 2Health News:Numerous Defense Personnel Granted Early Retirement Due to Mental Illness 2Health News:Cancer – Flushes Flesh and Fund 2Health News:Better Risk Management Could Cut MRSA Infection Rates 2
...omic solution and best value in high performance e...and ultra lightweight design reduce hand fatigue a...ver tip ejector , Color coding for easy volume ide...r performance use Hamilton AdvanTip Low Retention ...
Finnpipette BioControl Multichannel, 8 Channel 150-1500ul
...o Electronic Pipette is ideal for all liquid handl...llow display, ergonomically-placed operating butto...tting, dispensing, reverse pipetting and diluting ...he simple functions of a manual pipette without an...
...gn for Unparalleled Comfort Pick one of our pipet... trigger and ejector positionsright where they sho... pipettors are ergonomically designed to help avoi...of pipetting. Productivity In The Palm Of Your Ha...
Medicine Products: